SE443510B - Sett att framstella medel for forbettring av genomblodning och sarlekning, innehallande extrakt fran blod som befriats fran eggvita - Google Patents

Sett att framstella medel for forbettring av genomblodning och sarlekning, innehallande extrakt fran blod som befriats fran eggvita

Info

Publication number
SE443510B
SE443510B SE7800021A SE7800021A SE443510B SE 443510 B SE443510 B SE 443510B SE 7800021 A SE7800021 A SE 7800021A SE 7800021 A SE7800021 A SE 7800021A SE 443510 B SE443510 B SE 443510B
Authority
SE
Sweden
Prior art keywords
bradykinin
blood
extract
eggvita
exempt
Prior art date
Application number
SE7800021A
Other languages
English (en)
Swedish (sv)
Other versions
SE7800021L (sv
Inventor
G Dietze
M Wicklmayr
Original Assignee
Thera Ges Fuer Patente
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thera Ges Fuer Patente filed Critical Thera Ges Fuer Patente
Publication of SE7800021L publication Critical patent/SE7800021L/xx
Publication of SE443510B publication Critical patent/SE443510B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
SE7800021A 1977-01-03 1978-01-02 Sett att framstella medel for forbettring av genomblodning och sarlekning, innehallande extrakt fran blod som befriats fran eggvita SE443510B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2700043A DE2700043C2 (de) 1977-01-03 1977-01-03 Mittel zur Verbesserung der Durchblutung und Wundheilung

Publications (2)

Publication Number Publication Date
SE7800021L SE7800021L (sv) 1978-07-04
SE443510B true SE443510B (sv) 1986-03-03

Family

ID=5998057

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7800021A SE443510B (sv) 1977-01-03 1978-01-02 Sett att framstella medel for forbettring av genomblodning och sarlekning, innehallande extrakt fran blod som befriats fran eggvita

Country Status (9)

Country Link
US (1) US4177261A (ja)
JP (1) JPS53104713A (ja)
AT (1) AT356262B (ja)
CH (1) CH637018A5 (ja)
DE (1) DE2700043C2 (ja)
FR (1) FR2375868A1 (ja)
GB (1) GB1562871A (ja)
NL (1) NL188681C (ja)
SE (1) SE443510B (ja)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639247A5 (de) * 1979-01-23 1983-11-15 Thera Ges Fuer Patente Aminosaeuren und mineralsalze enthaltende infusionsloesung.
US5468737A (en) * 1982-05-07 1995-11-21 Carrington Laboratories, Inc. Wound healing accelerated by systemic administration of polysaccharide from aloe
HU190723B (en) * 1983-06-03 1986-10-28 Caola Kozmetikai Cosmetical composition containing protein-trace element adducts and process for producing them
GR82188B (ja) * 1983-06-03 1984-12-13 Caola Kozmetikai
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US4937230A (en) * 1985-01-24 1990-06-26 Procyte Corporation Method of healing wounds in horses
US5120831A (en) * 1985-02-08 1992-06-09 Procyte Corporation Metal-peptide compositions
US5214032A (en) * 1985-02-08 1993-05-25 Procyte Corporation GHL-CU pharmaceutical compositions and compounds
US5177061A (en) * 1985-02-08 1993-01-05 Procyte Corporation Method for stimulating hair growth using GHL-Cu complexes
US5550183A (en) * 1985-02-08 1996-08-27 Procyte Corporation Metal-peptide compositions and methods for stimulating hair growth
US4810693A (en) * 1985-02-08 1989-03-07 Procyte Corporation Method for inducing biological coverings in wounds
US5348943A (en) * 1985-02-08 1994-09-20 Procyte Corporation Cosmetic and skin treatment compositions
AT389640B (de) * 1985-10-16 1990-01-10 Chemie Holding Ag Verfahren zum gleichzeitigen trocknen und granulieren von extraktstoffen aus enteiweisstem kaelberblut
MX169205B (es) * 1987-05-11 1993-06-24 Procyte Corp Composicion para estimular el crecimiento del cabello
US5145838A (en) * 1989-08-30 1992-09-08 Procyte Corporation Methods and compositions for healing ulcers
US5023237A (en) * 1989-08-30 1991-06-11 Procyte Corporation Methods and compositions for healing ulcers
US5059588A (en) * 1989-10-13 1991-10-22 Procyte Corporation, Incorporated Methods and compositions for healing bone using gly his lys: copper
US5118665A (en) * 1990-02-09 1992-06-02 Procyte Corporation Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof
US5164367A (en) * 1990-03-26 1992-11-17 Procyte Corporation Method of using copper(ii) containing compounds to accelerate wound healing
JPH05163158A (ja) * 1991-12-13 1993-06-29 Sanwa Kagaku Kenkyusho Co Ltd 人尿性キニノゲナーゼを有効成分とする皮膚潰瘍の予防及び治療剤
KR0163563B1 (ko) * 1994-03-23 1998-12-01 김종인 피부질환 치료용 의약조성물
US5538945A (en) * 1994-06-17 1996-07-23 Procyte Corporation Stimulation of hair growth by peptide copper complexes
EP0726413B1 (de) * 1995-02-13 1998-11-25 Cci Ag Eigenmediumbetätigtes Ventil
US5733884A (en) * 1995-11-07 1998-03-31 Nestec Ltd. Enteral formulation designed for optimized wound healing
US20020076782A1 (en) * 1996-07-05 2002-06-20 John P.N. Rosazza Purified nitric oxide synthase
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6979307B2 (en) 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US20080199513A1 (en) * 1997-06-24 2008-08-21 Cascade Medical Enterprises, Llc Systems and methods for preparing autologous fibrin glue
AU2763099A (en) 1998-06-22 2000-01-10 Charles E. Worden Enriched platelet wound healant
US20080190857A1 (en) * 2005-03-22 2008-08-14 Cascade Medical Entrprises, Llc System and Methods of Producing Membranes
US20090197892A1 (en) * 2007-08-21 2009-08-06 Nawaz Ahmad Anhydrous compositions useful for attaining enhanced sexual wellness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2912359A (en) * 1955-05-04 1959-11-10 Developments Inc Wound healing agent obtained from blood and method of preparation
JPS5220524B1 (ja) * 1968-11-02 1977-06-04
DE2357507C3 (de) * 1973-11-17 1980-07-31 Bayer Ag, 5090 Leverkusen Mittel zur Fertilitätssteigemng

Also Published As

Publication number Publication date
US4177261A (en) 1979-12-04
NL188681B (nl) 1992-04-01
DE2700043A1 (de) 1978-07-06
CH637018A5 (de) 1983-07-15
GB1562871A (en) 1980-03-19
JPS53104713A (en) 1978-09-12
NL7800014A (nl) 1978-07-05
JPS6324976B2 (ja) 1988-05-23
FR2375868B1 (ja) 1982-06-11
AT356262B (de) 1980-04-25
DE2700043C2 (de) 1983-12-08
ATA4078A (de) 1979-09-15
FR2375868A1 (fr) 1978-07-28
NL188681C (nl) 1992-09-01
SE7800021L (sv) 1978-07-04

Similar Documents

Publication Publication Date Title
SE443510B (sv) Sett att framstella medel for forbettring av genomblodning och sarlekning, innehallande extrakt fran blod som befriats fran eggvita
Palmieri et al. Nutrition in wound healing: investigation of the molecular mechanisms, a narrative review
Anderson et al. Reduction of menstrual blood-loss by prostaglandin-synthetase inhibitors
EP0727985A1 (en) Composition and method for treating blood vessel disorders of the skin using vitamin k
JP2002518459A (ja) 修復プロセスを刺激する物質およびその適用方法
BR112020019192A2 (pt) Composição farmacêutica que compreende ácido deoxicólico
JP2017520555A (ja) 美容方法および美容製品
Ziccardi et al. Management of the oral and maxillofacial surgery patient with end-stage renal disease
US5668119A (en) Topical pharmaceutical containing heparin and method of treatment
CN104784193B (zh) 一种原人参二醇型三七皂苷的制药用途
Wicklmayr et al. The kallikrein-kinin system and muscle metabolism—clinical aspects
Penington Anaemia and polycythaemia with renal disease
Fitzgerald et al. A case of increased platelet anti-heparin factor in a patient with Raynaud's phenomena and gangrene, treated by aspirin
SU1139444A1 (ru) Способ введени нейротропных и гормональных препаратов
CN111000871A (zh) 一种口腔喷剂及其制备方法
Cope The chemical aspects of burn treatment
CN111514155A (zh) 三七皂苷Fc治疗脉管炎的用途
Aldrich Growth and development: The endocrine glands and growth (continued) the thyroid
AU662505B2 (en) Substance that can stop bleeding in surgical, medical and dental uses/substance powder 001 that can stop bleeding during surgery, after surgery, medicine, dentistry or any bleeding due to any causes
Allen et al. seriously impaired during their tinal illness. He correlated data as to the state of nutrition during health, the duration of the final illness, and the loss of weight during that time. Only patient, between 40 and 60 years were included. The evaluation of the state of nutrition at autopsy was based on the amount of adipose tissue deposited in the various body sites. The degree of atherosclerosis was graded by the extent
LINDNER et al. Effects of diltiazem on oxygen delivery and consumption after asphyxial cardiac arrest and resuscitation
Olimova HIRUDOTHERAPY IN THE COMPLEX TREATMENT OF DIABETIC FOOT SYNDROME
KR20210116131A (ko) 신 공법에 의한 저분자 콜라겐의 구강점막 흡수율을 조절할 수 있는 필름제 개발.
RU2258505C1 (ru) Способ лечения климактерического синдрома
JPH0574574B2 (ja)

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7800021-3

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7800021-3

Format of ref document f/p: F